Ildong inked with NBP Pharmaceutical to introduce China's first class new medicine
Published: 2007-12-10 06:56:00
Updated: 2007-12-10 06:56:00
Ildong Pharm has signed an exclusive license agreement with ShiJiaZhuang Pharma Group NBP Pharmaceutical Co. in Peking to distribute in Korea Butylphthalide soft capsule (3-nbutylphthalide; NBP), which is the first Class I new medicine in brain-vessel field of China.
Ildong said NBP is expect...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
